Methylprednisolone Sodium Succinate

CHEMBL1201081 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
496.5 g/mol
LogP
Phase
4

A sodium succinate salt form of methylprednisolone, a water-soluble injectable corticosteroid used for rapid treatment of severe allergic reactions, asthma, and inflammatory conditions in hospital settings.

Molekularmasse

496,5000 g/mol

TPSA

141,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Intermediate-acting synthetic glucocorticoid.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Intermediate-acting synthetic glucocorticoid.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+]

InChI

InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/p-1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1

Molecular Formula

C26H33NaO8

HBD / HBA

2 / 8

Rotierbare Bindungen

7

Schwere Atome

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A sodium succinate salt form of methylprednisolone, a water-soluble injectable corticosteroid used for rapid treatment of severe allergic reactions, asthma, and inflammatory conditions in hospital settings.

Intermediate-acting synthetic glucocorticoid.

Yes, Methylprednisolone Sodium Succinate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201081. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23680530. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.